Back

Effects of liraglutide and semaglutide on stroke subtypes in patients with type 2 diabetes: a post hoc analysis of the LEADER, SUSTAIN 6 and PIONEER 6 trials

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Stroke ePosters Prevention ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor William David Strain

University of Exeter, Exeter (United Kingdom of Great Britain & Northern Ireland)

24 More presentations in this session

Presentation thumbnail
Assessment of of twenty-five variants of polymorphic genes for lipid and carbohydrate metabolism, vascular inflammation and the neurotransmitter system in the first non-cardioembolic ischemic stroke
Assistant Professor V. Shishkova (Moscow, RU)
Abstract Slides
Presentation thumbnail
Height and risk of ischaemic stroke subtypes: a Mendelian randomisation study
Doctor A. Linden (Oxford, GB)
Abstract Slides
Presentation thumbnail
Are there mortality differences between men and women in all types of intracranial hemorrhages: subarachnoid, intraparenchymal and subdural? an analysis of the Spanish population
Doctor J. Fernandez De Bobadilla Osorio (Madrid, ES)
Abstract Slides
Presentation thumbnail
Blood-based biomarkers for the long-term prognosis after acute ischemic stroke - results of the Linz Stroke Unit (LISU) study
Doctor B. Dieplinger (Linz, AT)
Abstract Slides
Presentation thumbnail
Increasing time to thrombolysis is associated with worse long-term outcomes in patients with ischaemic stroke: a nationwide study
Ms A. Yafasova (Copenhagen, DK)
Abstract Slides

Access the full session

Session thumbnail
Stroke ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources